Date: 2022-09-22Category: Not ApplicableState: Union GovernmentCountry: Europe
Decision of The EEA Joint Committee No 124/2022 of 29 April 2022 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2022/1568]
**Summary:**
EEA Joint Committee Decision No. 124/2022, dated April 29, 2022, amends Annex II (Technical regulations, standards, testing and certification) to the Agreement on the European Economic Area (EEA). This decision incorporates two Commission Implementing Decisions into the EEA Agreement:
1. **Commission Implementing Decision (EU) 2021/2146 of December 3, 2021:** This decision postpones the expiry date of approval for N,N-diethyl-meta-toluamide (DEET) for use in biocidal products of product-type 19. (OJ L 433, 6.12.2021, p. 23).
2. **Commission Implementing Decision (EU) 2021/2148 of December 3, 2021:** This decision addresses unresolved objections regarding the terms and conditions for the authorization of the biocidal product family "Oxybio" in accordance with Article 36 of Regulation (EU) No 528/2012. (OJ L 434, 6.12.2021, p. 1).
The authentic texts of Implementing Decisions (EU) 2021/2146 and (EU) 2021/2148 in Icelandic and Norwegian languages will be published in the EEA Supplement to the Official Journal of the European Union.
This Decision entered into force on April 30, 2022, following the completion of all notifications required under Article 103(1) of the EEA Agreement. The decision will be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Key Entities Referenced
EEA Joint Committee: The governing body responsible for decisions related to the Agreement on the European Economic Area (EEA).
EEA Agreement: Agreement on the European Economic Area.
Commission Implementing Decision EU 2021/2146: A decision by the European Commission regarding the expiry date of approval of N,N-diethyl-meta-toluamide.
N,N-diethyl-meta-toluamide: A chemical substance used in biocidal products, the approval of which is subject to Commission Implementing Decision EU 2021/2146.
Commission Implementing Decision EU 2021/2148: A decision by the European Commission regarding unresolved objections to the authorisation of the biocidal product family Oxybio.
Oxybio: A biocidal product family subject to Commission Implementing Decision EU 2021/2148.
Regulation EU No 528/2012: Regulation of the European Parliament and of the Council concerning the making available on the market and use of biocidal products.
Brussels: City in Belgium, where the decision was made.
22.9.2022 EN Official Journal of the European Union L 246/67
DECISION OF THE EEA JOINT COMMITTEE No 124/2022
of 29 April 2022
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
[2022/1568]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98
thereof,
Whereas:
(1) Commission Implementing Decision (EU) 2021/2146 of 3 December 2021postponing the expiry date of approval
of N,N-diethyl-meta-toluamide for use in biocidal products of product-type 19(1)is to be incorporated into the EEA
Agreement.
(2) Commission Implementing Decision (EU) 2021/2148 of 3 December 2021on the unresolved objections regarding
terms and conditions of the authorisation of the biocidal product family Oxybio in accordance with Article 36 of
Regulation (EU) No 528/2012 of the European Parliament and of the Council(2)is to be incorporated into the EEA
Agreement.
(3) Annex II to the EEA Agreement should therefore be amended accordingly,
HAS ADOPTED THIS DECISION:
Article 1
The following points are inserted after point 12zzzzzzzp (Commission Implementing Decision (EU) 2021/1839) of
Chapter XV of Annex II to the EEA Agreement:
‘12zzzzzzzq. 32021 D 2146: Commission Implementing Decision (EU) 2021/2146 of 3 December 2021postponing the
expiry date of approval of N,N-diethyl-meta-toluamide for use in biocidal products of product-type 19
(OJ L 433, 6.12.2021, p. 23).
12zzzzzzzr. 32021 D 2148: Commission Implementing Decision (EU) 2021/2148 of 3 December 2021 on the
unresolved objections regarding terms and conditions of the authorisation of the biocidal product family
Oxybio in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of
the Council (OJ L 434, 6.12.2021, p. 1).’
Article 2
The texts of Implementing Decisions (EU) 2021/2146 and (EU) 2021/2148 in the Icelandic and Norwegian languages, to be
published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 30 April 2022, provided that all the notifications under Article 103(1) of the EEA
Agreement have been made*.
(1) OJ L 433, 6.12.2021, p. 23.
(2) OJ L 434, 6.12.2021, p. 1.
(*) No constitutional requirements indicated.L 246/68 EN Official Journal of the European Union 22.9.2022
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European
Union.
Done at Brussels, 29 April 2022.
For the EEA Joint Committee
The President
Nicolas VON LINGEN